Atila BioSystems is focusing on developing novel chemistry for multiplex nucleic acid amplification and detection technologies for clinical diagnostic applications. The technologies include novel isothermal amplification, ultrahigh multiplex PCR, single cell amplification, whole genome amplification, single molecular detection, etc. Products include cancer diagnostics (hotspot cancer mutation detection), HPV (cervical cancer), DNA sequencing (NGS library preparation), digital PCR and Down Syndrome (NIPT), infection disease.